Company / Accounts Receivable
SRx Health Solutions, Inc. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$9.3M
FY2025
5-year range
$4.4M / $9.3M
FY2021-FY2025
Trend
+72.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has fluctuated over the past 9 years, ranging from $0 in FY2017 to $9M in FY2025.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of +14.9%.
Improved from $4M to $9M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +11.2%
- 5-Year CAGR
- +14.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +14.9%, indicating consistent growth.
- In FY2025, accounts receivable increased 72.7% year-over-year.
- Lowest accounts receivable in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.3M | +72.7% |
| FY2024 | $5.4M | +23.4% |
| FY2023 | $4.4M | -35.4% |
| FY2022 | $6.7M | -0.7% |
| FY2021 | $6.8M | +46.7% |
| FY2020 | $4.6M | -20.5% |
| FY2019 | $5.8M | - |
| FY2018 | - | - |
| FY2017 | $0 | -100.0% |
| FY2016 | $45 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026